What medication can help a patient with hair loss grow hair?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 11, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Medication for Hair Growth

Start with topical minoxidil 5% applied twice daily as first-line therapy, and consider adding platelet-rich plasma (PRP) injections for enhanced results if monotherapy proves insufficient after 4-6 months. 1, 2

First-Line Treatment: Topical Minoxidil

Topical minoxidil 5% is the FDA-approved first-line pharmacologic treatment for androgenetic alopecia and must be continued indefinitely to maintain results. 1, 2

Dosing and Application

  • Apply 1 mL of 5% minoxidil solution twice daily directly to the scalp 2
  • For women, 5% minoxidil foam once daily is also effective and FDA-approved 3
  • Hair must be shampooed and detangled before application, with no hair products present 1

Expected Timeline

  • Initial results may appear as early as 2 months with consistent twice-daily use 2
  • Most patients require at least 4 months before seeing visible results 2
  • Temporary increased hair shedding for up to 2 weeks is expected initially as old hairs are replaced by new growth 2
  • If no improvement after 4 months, discontinue and consider alternative therapy 2

Efficacy Data

  • In women with female pattern hair loss, 5% minoxidil demonstrated superiority over 2% formulation in patient-assessed treatment benefit at 48 weeks 4
  • 80% clinical cure rate (increased hair intensity) has been documented in comparative trials 5
  • Increases both hair count and hair diameter significantly after 6 months of treatment 6

Alternative: Oral Minoxidil

Low-dose oral minoxidil (1 mg daily) represents an effective alternative for patients with poor compliance to topical formulations, though topical remains preferred first-line. 7, 6

When to Consider

  • Patients experiencing scalp irritation from topical formulation 7
  • Poor adherence to twice-daily topical application 7
  • Difficulty applying topical medication due to hair texture concerns 7

Dosing

  • 1 mg daily oral minoxidil shows comparable efficacy to topical 5% solution 6
  • Both formulations show significant improvement in hair diameter after 6 months (p < 0.001) 6
  • Over 60% patient satisfaction in both oral and topical groups 6

Important Caveat

Topical minoxidil demonstrated better photographic improvement in hair density at multiple scalp locations compared to 1 mg oral formulation, though the difference was not statistically significant 6

Advanced Combination Therapy: PRP with Minoxidil

For patients requiring enhanced results beyond minoxidil monotherapy, combination therapy with PRP injections provides superior outcomes. 1, 8

When to Add PRP

  • Poor response to minoxidil monotherapy after 4-6 months 1
  • Patients seeking maximal hair density improvement 8
  • More severe grades of androgenetic alopecia 8

PRP Protocol

  • 3-5 treatment sessions spaced 1 month apart during initial phase 1
  • Use 5-7 mL of nonactivated PRP per session 1
  • Inject at 0.05 to 0.1 mL/cm² at 1 cm intervals 1
  • 90-degree angle, 2-4 mm depth using 30G × 4 mm needles 1
  • Maintenance: 1 session every 6 months after initial treatment phase 1

Anesthesia Requirement

Apply pharmaceutical-grade topical anesthetic cream before PRP injection due to significant pain associated with the procedure. 1

Combination Therapy Outcomes

  • PRP combined with topical minoxidil 5% is the most effective treatment modality, superior to either treatment alone 8
  • Combination therapy achieves 57% median increase in terminal hair density versus 48% with minoxidil alone at 32 weeks 1
  • 83% of patients achieve negative hair pull test (reduced hair fragility) with combination therapy 1
  • Hair density increased 1.74 times and hair diameter increased 14.3 times in combination therapy groups 8

PRP Technical Details

  • Nonactivated PRP shows 31% greater improvement in hair density compared to activated PRP 1
  • Target platelet concentration: 1 to 1.5 million platelets per µL 1
  • 25% improvement in hair density at 2 months predicts sustained response at 6 months 1

Monitoring Treatment Response

Assessment Methods

  • Standardized before-and-after photographs at baseline and follow-up 1
  • Trichoscopy to evaluate hair density and diameter 1
  • Hair pull test to assess hair fragility 1
  • Patient self-assessment questionnaires for subjective improvement 1
  • Monitor terminal versus vellus hair ratio as key efficacy indicator 1

Follow-Up Schedule

  • Evaluate response at 2,4, and 6 months for minoxidil monotherapy 2
  • For combination therapy, assess at 6 months and 1 year 1
  • Maximum response typically achieved by 6 months 1

Critical Warnings and Contraindications

Who Should NOT Use Minoxidil 5%

  • Women should not use 5% minoxidil solution (use 5% foam or 2% solution instead) as studies show it works no better than 2% in women and may cause facial hair growth 2
  • Pregnant or breastfeeding women - minoxidil may be harmful 2
  • Children under 18 years old 2
  • Patients with hair loss from medications, nutritional deficiencies, hypothyroidism, chemotherapy, or scarring conditions 2

Common Pitfall

Discontinuing minoxidil leads to reversal of all hair growth benefits - patients must understand this is lifelong therapy if effective 1, 2

Alternative Medication: Finasteride (Men Only)

Oral finasteride 1 mg daily demonstrates superior efficacy to topical minoxidil in male androgenetic alopecia, with 80% clinical cure rate versus 52% for minoxidil. 5

Key Points

  • More effective than topical minoxidil 5% in head-to-head comparison (p < 0.05) 5
  • Side effects include loss of libido in 15% of patients, which resolve upon discontinuation 5
  • Not appropriate for women of childbearing potential due to teratogenic effects

Treatment Algorithm Summary

  1. Start all patients with topical minoxidil 5% (1 mL twice daily) 1, 2
  2. Assess response at 4 months - if no improvement, consider discontinuing 2
  3. If partial response or inadequate improvement at 6 months, add PRP therapy (3 monthly sessions) 1
  4. For men with poor minoxidil response, consider switching to oral finasteride 1 mg daily 5
  5. For patients intolerant of topical formulation, switch to oral minoxidil 1 mg daily 7, 6
  6. Maintenance: Continue minoxidil indefinitely + PRP every 6 months if using combination therapy 1, 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.